BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9314612)

  • 1. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
    Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH
    Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic approach to antiepileptic drug interactions.
    Anderson GD
    Ann Pharmacother; 1998 May; 32(5):554-63. PubMed ID: 9606477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
    Spina E; Pisani F; Perucca E
    Clin Pharmacokinet; 1996 Sep; 31(3):198-214. PubMed ID: 8877250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential pharmacokinetic interaction between felbamate and phenobarbital.
    Gidal BE; Zupanc ML
    Ann Pharmacother; 1994 Apr; 28(4):455-8. PubMed ID: 8038465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine.
    Egnell AC; Houston B; Boyer S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1251-62. PubMed ID: 12606595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M; Riva R; Albani F; Baruzzi AA
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
    Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
    Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats.
    Borowicz KK; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Pharmacol Biochem Behav; 2004 May; 78(1):103-10. PubMed ID: 15159139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
    Rekling JC
    Neurosci Lett; 2003 Jan; 335(3):167-70. PubMed ID: 12531459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies.
    Benedetti MS
    Fundam Clin Pharmacol; 2000; 14(4):301-19. PubMed ID: 11030437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of felbamate in children.
    Kelley MT; Walson PD; Cox S; Dusci LJ
    Ther Drug Monit; 1997 Feb; 19(1):29-36. PubMed ID: 9029743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of felbamate on the pharmacokinetics of phenobarbital.
    Reidenberg P; Glue P; Banfield CR; Colucci RD; Meehan JW; Radwanski E; Mojavarian P; Lin CC; Nezamis J; Guillaume M
    Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions of the new antiepileptic drugs.
    Rambeck B; Specht U; Wolf P
    Clin Pharmacokinet; 1996 Oct; 31(4):309-24. PubMed ID: 8896946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
    Potschka H; Fedrowitz M; Löscher W
    Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of felbamate on carbamazepine and its major metabolites.
    Wagner ML; Remmel RP; Graves NM; Leppik IE
    Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of felbamate on valproic acid disposition.
    Wagner ML; Graves NM; Leppik IE; Remmel RP; Shumaker RC; Ward DL; Perhach JL
    Clin Pharmacol Ther; 1994 Nov; 56(5):494-502. PubMed ID: 7955813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.
    Riva R; Albani F; Contin M; Baruzzi A
    Clin Pharmacokinet; 1996 Dec; 31(6):470-93. PubMed ID: 8968658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.